taiwanhilt.blogg.se

Congress vienna 2017
Congress vienna 2017











congress vienna 2017

Petoussi-Henss N, Ocampo Ramos J, Zankl M, Li W, Rühm W. Radiomics analysis predicts – and M-stage of primary cervical cancer using multiple PET/MR-derived quantitative features. Grueneisen J, Nensa F, Herrmann K, Bariye A, Forsting M, Umutlu L. Feasibility of the state-of-the-art PET/CT system performance harmonization.

congress vienna 2017

Kaalep A, Sera T, Rijnsdorp S, Yaqub M, Talsma A, Lodge MA, Boellaard R, et al. PET 20.0: a cost-efficient, 2mm spatial resolution total body PET with point sensitivity up to 22% and adaptive axial FOV of maximum 2.00m. Vandenberghe S, Mikhalyova E, Brans B, Defrise M, Lahoutte T, Muylle K, et al.

congress vienna 2017

A promising PET detector design that achieves 100 ps FWHM coincidence time resolution.

congress vienna 2017

This Highlights Lecture could only be a brief summary of the large amount of data presented and discussed during the meeting, which can be found in much greater detail in the Congress proceedings book, published as volume 44, supplement 2 of the European Journal of Nuclear Medicine and Molecular Imaging in October 2017.Ībstracts Annual congress EANM 2017 Highlights Nuclear medicine PET Radionuclide therapy and dosimetry Radiopharmaceuticals SPECT.Ĭates CS, Levin CS. The Congress was a unique opportunity to be thoroughly updated on this research. A particular focus of the Congress was on targeted radionuclide-based therapies, which all show promising and great innovations. They cover the diverse areas of nuclear medicine, with particular focus on oncology, cardiovascular science, neurology, technological innovation and novel tracers, and also other clinical sciences. This review summarizes the major scientific contributions which were selected from more than 1,900 submitted abstracts, and presented in the closing highlights session. Additionally, the latest technology and innovations in the field were presented, and added to the success of the Congress. These lectures were devoted to nuclear medicine imaging and therapy, including hybrid imaging and molecular life sciences. Participants were presented with an excellent programme consisting of symposia, and scientific and featured sessions, CME sessions, and plenary lectures. As always, the Congress was a great success: more than 6,379 participants came from 90 countries from all continents. The 30th Annual Congress of the European Association of Nuclear Medicine (EANM) was held in Vienna, Austria, from 21 to 25 October 2017 under the chairmanship of Professor Francesco Giammarile.













Congress vienna 2017